The issue consists of a fresh issuance of 83.28 lakh shares, amounting to Rs 71.62 crore, along with an offer for sale of 20 lakh shares, totaling Rs 17.20 crore. The company plans to utilize the net ...

(Reuters) - Johnson & Johnson said on Monday it would buy neurological drug maker Intra-Cellular Therapies for $14.6 billion, its biggest deal in more than two years, boosting its presence in the ...